Opioid Antagonist [EPC]

961 reported adverse events

Drugs of this class: BUPRENORPHINE AND NALOXONE

These side effects are most commonly reported by patients taking drugs of the Opioid Antagonist [EPC] class:

# Side effect Count
0 NAUSEA 116
1 INJECTION SITE REACTION 91
2 DRUG WITHDRAWAL SYNDROME 78
3 DRUG INEFFECTIVE 72
4 VOMITING 69
5 HEADACHE 68
6 PRODUCT SUBSTITUTION ISSUE 56
7 DRUG ABUSE 55
8 WITHDRAWAL SYNDROME 53
9 TOXICITY TO VARIOUS AGENTS 49
See all common reactions for Opioid Antagonist [EPC]

Drugs of the Opioid Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT DOSAGE FORM ISSUE 7 0.0145
1 PILOERECTION 10 0.0091
2 PRODUCT SOLUBILITY ABNORMAL 36 0.0071
3 YAWNING 8 0.0030
4 PRODUCT TAMPERING 5 0.0028
5 JAUNDICE NEONATAL 5 0.0026
6 DENTAL CARIES 22 0.0020
7 DRUG DIVERSION 10 0.0016
8 POTENTIATING DRUG INTERACTION 5 0.0015
9 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 10 0.0015
See all enriched reactions for Opioid Antagonist [EPC]